Icosapent Ethyl Effects on Heart Disease and Inflammation
Part of Heart & circulation clinical trials.
This study tests whether a medication called icosapent ethyl (a purified fish oil) can help reduce plaque buildup in heart arteries and lower inflammation in people with heart disease. Researchers will use imaging and blood tests to see if it protects your heart.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with chronic heart disease (blocked arteries) or have had a recent heart attack
- Your fasting triglycerides (a type of blood fat) are elevated at 1.7 mmol/L or higher
- You are willing and able to give informed consent and understand the study purpose
- You are not pregnant, planning pregnancy, or breastfeeding
- You do not have a severe allergy to icosapent ethyl or fish oil products
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a medication called icosapent ethyl (a type of fish oil) to see if it can reduce inflammation in dangerous heart plaques. It might help prevent heart attacks or strokes in people with certain high-risk plaque features.
This trial tests whether a prescription fish oil pill (icosapent ethyl) can further lower the risk of heart problems in people who already have heart disease and are taking a statin. It may help if your cholesterol and inflammation levels are in a certain range.
This trial tests if a medicine called icosapent ethyl can reduce inflammation in blood vessels for adults hospitalized with pneumonia. It aims to see if this treatment can help prevent complications.
This trial tests whether natural extracts and probiotics can improve gut health in people who have had a recent heart attack (Acute Coronary Syndrome). It uses special exams to measure changes in gut bacteria.
This trial tests whether higher doses of cholesterol-lowering medication (statins) can slow down plaque buildup in the heart arteries of younger and middle-aged adults with stable chest pain. It may help prevent heart attacks and the need for procedures like stents.
This study tests whether a medication called a PCSK9 inhibitor (a type of drug that lowers bad cholesterol) can improve the buildup of plaque in heart arteries. It may be an option for people with coronary artery disease who have not been helped enough by statins alone.
Hear when a new Chronic Coronary Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.